Enzychem Lifesciences Corporation (183490.KQ)

KRW 1147.0

(-1.12%)

Gross Profit Summary of Enzychem Lifesciences Corporation

Enzychem Lifesciences Corporation's latest annual gross profit in 2023 was 3.29 Billion KRW , up 103.47% from previous year.
Enzychem Lifesciences Corporation's latest quarterly gross profit in 2024 Q2 was 1.04 Billion KRW , down -20.44% from previous quarter.
Enzychem Lifesciences Corporation reported a annual gross profit of 1.61 Billion KRW in annual gross profit 2022, up 529.59% from previous year.
Enzychem Lifesciences Corporation reported a annual gross profit of -376.78 Million KRW in annual gross profit 2021, down -128.46% from previous year.
Enzychem Lifesciences Corporation reported a quarterly gross profit of 1.04 Billion KRW for 2024 Q2, down -20.44% from previous quarter.
Enzychem Lifesciences Corporation reported a quarterly gross profit of 984.66 Million KRW for 2023 Q4, up 89.72% from previous quarter.

Annual Gross Profit Chart of Enzychem Lifesciences Corporation (2023 - 2016)

Historical Annual Gross Profit of Enzychem Lifesciences Corporation (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	3.29 Billion KRW	103.47%
2022	1.61 Billion KRW	529.59%
2021	-376.78 Million KRW	-128.46%
2020	1.32 Billion KRW	-37.65%
2019	2.12 Billion KRW	-44.86%
2018	3.85 Billion KRW	8.46%
2017	3.55 Billion KRW	19.1%
2016	2.98 Billion KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	1.6 Billion KRW	63.1%
2024 Q2	1.04 Billion KRW	-20.44%
2023 Q4	984.66 Million KRW	89.72%
2023 Q1	1.14 Billion KRW	63.12%
2023 Q2	645.91 Million KRW	-43.53%
2023 FY	3.29 Billion KRW	103.47%
2023 Q3	519 Million KRW	-19.65%
2022 Q2	393.92 Million KRW	37.57%
2022 FY	1.61 Billion KRW	529.59%
2022 Q4	701.26 Million KRW	195.75%
2022 Q3	237.11 Million KRW	-39.81%
2022 Q1	286.35 Million KRW	288.45%
2021 Q1	724.25 Million KRW	817.02%
2021 FY	-376.78 Million KRW	-128.46%
2021 Q4	-151.95 Million KRW	17.91%
2021 Q3	-185.11 Million KRW	69.71%
2021 Q2	-611.15 Million KRW	-184.38%
2020 Q4	78.97 Million KRW	-84.23%
2020 Q3	500.79 Million KRW	66.3%
2020 Q1	938.63 Million KRW	317.33%
2020 Q2	301.14 Million KRW	-67.92%
2020 FY	1.32 Billion KRW	-37.65%
2019 Q3	985.61 Million KRW	43.36%
2019 Q1	766.4 Million KRW	17.61%
2019 FY	2.12 Billion KRW	-44.86%
2019 Q4	224.91 Million KRW	-77.18%
2019 Q2	687.51 Million KRW	-10.29%
2018 FY	3.85 Billion KRW	8.46%
2018 Q2	1.15 Billion KRW	46.68%
2018 Q4	651.62 Million KRW	-61.06%
2018 Q3	1.67 Billion KRW	45.07%
2018 Q1	786.38 Million KRW	-51.18%
2017 Q2	1.05 Billion KRW	0.0%
2017 FY	3.55 Billion KRW	19.1%
2017 Q3	860.92 Million KRW	-18.74%
2017 Q4	1.61 Billion KRW	87.1%
2016 FY	2.98 Billion KRW	0.0%

Peer Gross Profit Comparison of Enzychem Lifesciences Corporation

Name	Gross Profit	Gross Profit Difference
HLB Pharmaceutical Co., Ltd	82.98 Billion KRW	96.031%
CMG Pharmaceutical Co., Ltd.	43.7 Billion KRW	92.464%
Celltrion Pharm, Inc.	116.95 Billion KRW	97.184%
Huons Global Co., Ltd.	417.8 Billion KRW	99.212%
DongKook Pharmaceutical Co., Ltd.	405.04 Billion KRW	99.187%
Humedix Co., Ltd.	68.04 Billion KRW	95.16%
Boditech Med Inc.	76.7 Billion KRW	95.706%
EuBiologics Co., Ltd.	32.65 Billion KRW	89.916%
FutureChem Co.,Ltd	758.27 Million KRW	-334.342%
Huons Co., Ltd.	285.93 Billion KRW	98.848%
BNC Korea Co., Ltd.	31.97 Billion KRW	89.701%
AptaBio Therapeutics Inc.	78.49 Million KRW	-4095.594%